Neuzumab 150 mg Injection
  1. Home
  2. Pharma Products
  3. Lupin Ltd
  4. Neuzumab 150 mg Injection

Neuzumab 150 mg Injection

Neuzumab 150 mg Injection contains trastuzumab 150 mg, a monoclonal antibody used as targeted cancer therapy. It is mainly used for HER2-positive breast cancer and certain HER2-positive stomach cancers. The medicine is administered by a qualified healthcare professional through the prescribed intravenous or subcutaneous route.

BUY NOW

Category

Trastuzumab works by binding to the HER2 protein on cancer cells and blocking signals that promote their growth and survival. It may be used alone or with other anticancer medicines depending on the cancer type and treatment protocol. Patients require monitoring for infusion-related reactions and heart function because trastuzumab can cause cardiac complications in some patients. The dosage and treatment schedule are individualized by the treating oncologist according to the patient’s condition and response to therapy.

Technical Specification

Specification Details
Active Ingredient Trastuzumab
Strength 150 mg
Dosage Form Injection
Route of Administration Intravenous or Subcutaneous
Pack Size 1 Vial, 10 mL
Manufacturer / Marketer Lupin Ltd

Product Also Known As

Neuzumab 150 mg Injection, Neuzumab 150mg Injection, Neuzumab 150 mg Vial, Neuzumab 150mg Vial, Trastuzumab 150 mg Injection, Trastuzumab 150mg Injection, Trastuzumab 150 mg Vial